Substantial Effects of Luseogliflozin Revealed by Analyzing Responses to Postprandial Hyperglycemia: Post Hoc Subanalyses of a Randomized Controlled Study

INTRODUCTION: In our previous study investigating effects of luseogliflozin, a sodium–glucose cotransporter 2 inhibitor, on 24-h glycemic variability by continuous glucose monitoring (CGM), luseogliflozin elicited parallel downward shifts in fasting and postprandial glucose levels. However, further...

Descripción completa

Detalles Bibliográficos
Autores principales: Samukawa, Yoshishige, Omiya, Hirohisa, Watase, Hirotaka, Nozaki, Kazunari, Sakai, Soichi, Nishimura, Rimei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4939154/
https://www.ncbi.nlm.nih.gov/pubmed/27255763
http://dx.doi.org/10.1007/s12325-016-0350-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4939154/
https://www.ncbi.nlm.nih.gov/pubmed/27255763
http://dx.doi.org/10.1007/s12325-016-0350-5

Ejemplares similares